Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Single Dose Neladenoson Bialanate in Chronic Heart Failure
NCT01945606Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neladenoson bialanate in heart failure (HF), sponsored by Bayer. Started Nov 2013; status: completed.
02
Drugs
neladenoson bialanate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01945606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945606.